MedTech News
.................... by Andrew Celentano
FDA approves Guardant Health’s next-generation liquid biopsy panel
According to Guardant, Guardant360 Liquid assesses a ‘100x wider’ genomic footprint to guide cancer treatment decisioning than its predecessor.
Sentante wins CE mark for endovascular surgical robot
Sentante announced today that it received CE mark for its flagship endovascular surgical robot platform for treating stroke.
For real heart protection, the weekly exercise number climbs far beyond current advice
Researchers from Macao Polytechnic University, China, set out to look at how both exercise levels and cardiorespiratory fitness, as measured by VO2 max, affected the risk of cardiovascular disease.
A protective gel for a future without insulin injections
Researchers from the University of Geneva (UNIGE) and Geneva University Hospitals (HUG) have reached a significant advance in the fight against type 1 diabetes.
Blood test spots failing prostate cancer treatment within 6-12 weeks, study finds
A new blood test could help doctors identify whether a treatment for advanced prostate cancer is failing weeks earlier than current tests, according to a U.K.-wide study led by UCL researchers.
Once-nightly pill treats causes of airway collapse to control obstructive sleep apnea in large clinical trial
“These results provide encouraging evidence that targeting neuromuscular dysfunction can translate into meaningful clinical outcomes, aligning with our evolving understanding of the disease biology,” said first author Patrick John Strollo, MD, a sleep medicine physician at the University of Pittsburgh Medical Center.
SeeTreat’s ART.1-US Software is FDA Cleared for clinical use in the USA
SYDNEY, May 18, 2026 /PRNewswire/ — SeeTreat’s ART.1-US software delivering automated adaptive decision support for every patient at every treatment is cleared for use in the USA. From today, US clinics with Varian or Elekta CT linear accelerators, will be able to access daily evaluations of radiotherapy dose to patients’ changing anatomy. With ART.1-US, clinical teams can now decide the right time for a new radiotherapy plan in 95+ seconds[1], and download supporting clinical documentation.
Galvanize Therapeutics wins FDA nod for pulsed electric field generator for surgical ablation
Galvanize Therapeutics announced today that it received FDA clearance for its Aliya EX generator for the surgical ablation of soft tissue.